Oliver Luxxe Assets LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1666239 GLADSTONE, NJ

Position in HALO

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$2,584,005

-$659,128 QoQ

Shares Held

33,014

-34.2% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

#10

of 70 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Jun 30, 2026

Oliver Luxxe Assets LLC holds $10,072,172 across 5 Biotechnology names. HALO ranks #2 (25.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	18,860	$4,544,694
2	HALO	Halozyme Therapeutics, Inc. This page	33,014	$2,584,005
3	CPRX	Catalyst Pharmaceuticals, Inc.	49,744	$1,563,453
4	INVA	Innoviva, Inc.	58,957	$1,338,913
5	GANX	Gain Therapeutics, Inc.	20,250	$41,107

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,584,005	33,014	-34.2%	Shares	Sole	2026-07-09
2026-03-31	$3,243,133	50,180	+19.4%	Shares	Sole	2026-04-08
2025-12-31	$2,827,407	42,012	+0.5%	Shares	Sole	2026-01-08
2025-09-30	$3,065,538	41,799	+1.9%	Shares	Sole	2025-10-24
2025-06-30	$2,134,588	41,034	+2.0%	Shares	Sole	2025-07-14
2025-03-31	$2,567,650	40,239	+44.9%	Shares	Sole	2025-05-14
2024-12-31	$1,327,683	27,770	0.0%	Shares	Sole	2025-01-21
2024-09-30	$1,589,554	27,770	—	Shares	Sole	2024-10-11
No filing history on record for this holder in this stock.